James Alexander Fagin, MD

Publications

193

3 grants

MPI
Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.
NCI · 2026–2031 · via NIH RePORTER
R01CA303958-01A1
MPI
Improving efficacy of radioiodine treatment of thyroid cancer
NCI · 2021–2026 · via NIH RePORTER
R01CA249663-05
PI
Targeting immune suppressive microenvironment in ATC
NCI · 2021–2026 · via NIH RePORTER
R01CA255211-05

Completed grants (8)

PI
Molecular Pathophysiology of Thyroid Cell Growth
NCI · 1989–2024 · via NIH RePORTER
R01CA050706-31
MPI
Head and Neck Training Program in Surgical Oncology
NCI · 1992–2024 · via NIH RePORTER
T32CA009685-30
PI
Oncogenic Events in Thyroid Neoplasia
NCI · 1996–2021 · via NIH RePORTER
R01CA072597-21
PI
Career Development Program
NCI · 2014–2020 · via NIH RePORTER
P50CA172012-05
PI
Maximizing effectiveness of radioiodine therapy by inhibition of MAPK signaling
NCI · 2013–2018 · via NIH RePORTER
R01CA173592-02
PI
A Validated Resource of Thyroid Cancer Cell Lines for Pathway Discovery
NCI · 2009–2012 · via NIH RePORTER
RC1CA147371-02
PI
BIOLOGICAL AND PHYSIOLOGICAL SCIENCES REVIEW SECTION
NIH · 1997–2011 · via NIH RePORTER
No publications yet
U09RG000142-09S5
PI
Paracrine IGF/GFBP Interactions In Vivo
NIDDK · 1998–2009 · via NIH RePORTER
R01DK054216-11